According to the 2021 World Health Organization (WHO) classification of central nervous system (CNS) tumors, isocitrate dehydrogenase (IDH)-wildtype GBM is designated CNS-WHO grade 4 [2]. This evidence concerns the gene IDH3A and glioblastoma.